Clinical efficiency and safety of combined medicine Fozicard-H at patients with high risk arterial hypertension
Keywords:
fozicard-hAbstract
Arterial hypertension (AH) is independent risk factor of myocardial infarction, brain stroke, chronic heart failure (CHF)
and hypertensive nephropathy and death from cardiovascular diseases. Main goal of treatment of AH – maximal lowering of
risk of cardiovascular morbidity and mortality. Clinical efficiency and safety of combined medicine Fozicard-H are presented
at this article. Fozicard-H is metabolic neutral.
References
КЛИНИЧЕСКАЯ ЭФФЕКТИВНОСТЬ И БЕЗОПАСНОСТЬ ПРИМЕНЕНИЯ КОМБИНИРОВАННОГО ПРЕПАРАТА ФОЗИКАРД-Н У БОЛЬНЫХ АРТЕРИАЛЬНОЙГИПЕРТОНИЕЙ ВЫСОКОГО РИСКА
Downloads
Published
2026-03-06
Issue
Section
Статьи
License
Copyright (c) 2026 Л.К. Каражанова, Д.А. Мансурова, Г.Б. Батенова, М.А. Капакова (Автор)
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
Clinical efficiency and safety of combined medicine Fozicard-H at patients with high risk arterial hypertension. (2026). Рецензируемый медицинский научно-практический журнал «Наука и здравоохранение», 13(2), 50-52. https://newjournal.ssmu.kz/index.php/journalssmu/article/view/2892